High-capacity adenoviral vectors for gene transfer and somatic gene therapy

被引：137
|
作者：
Kochanek, S [1 ]
机构：
[1] Univ Cologne, Ctr Mol Med, D-50931 Cologne, Germany
来源：
HUMAN GENE THERAPY | 1999年 / 10卷 / 15期
关键词：
D O I：
10.1089/10430349950016807
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
The availability of efficient and nontoxic gene delivery technologies is fundamental to the translation of therapeutic concepts into clinical practice by gene transfer. High-capacity adenoviral (HC-Ad) vectors are characterized by the ability to transduce cells in vitro and in vivo with more than 30 kb of nonviral DNA, This quality allows simultaneous gene transfer of several expression cassettes, large promoters, and some genes in their natural genomic context. Because all viral coding sequences are removed from these vectors, safety is considerably improved compared with previous-generation adenoviral vectors.
引用
收藏
页码：2451 / 2459
页数：9
相关论文
共 50 条
  • [1] Development of high-capacity adenoviral vectors for gene therapy
    Kochanek, S
    THROMBOSIS AND HAEMOSTASIS, 1999, 82 (02) : 547 - 551
  • [2] High-Capacity Adenoviral Vectors: Expanding the Scope of Gene Therapy
    Ricobaraza, Ana
    Gonzalez-Aparicio, Manuela
    Mora-Jimenez, Lucia
    Lumbreras, Sara
    Hernandez-Alcoceba, Ruben
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (10)
  • [3] High-capacity, helper-dependent, "gutless" adenoviral vectors for gene transfer into brain
    Lowenstein, PR
    Thomas, CE
    Umana, P
    Gerdes, CA
    Verakis, T
    Boyer, O
    Tondeur, S
    Klatzmann, D
    Castro, MG
    GENE THERAPY METHODS, 2002, 346 : 292 - 311
  • [4] Fetal muscle gene transfer is not enhanced by an RGD capsid modification to high-capacity adenoviral vectors
    R Bilbao
    D P Reay
    T Hughes
    V Biermann
    C Volpers
    L Goldberg
    J Bergelson
    S Kochanek
    P R Clemens
    Gene Therapy, 2003, 10 : 1821 - 1829
  • [5] Fetal muscle gene transfer is not enhanced by an RGD capsid modification to high-capacity adenoviral vectors
    Bilbao, R
    Reay, DP
    Hughes, T
    Biermann, V
    Volpers, C
    Goldberg, L
    Bergelson, J
    Kochanek, S
    Clemens, PR
    GENE THERAPY, 2003, 10 (21) : 1821 - 1829
  • [6] Adenoviral vectors for gene transfer and therapy
    Volpers, C
    Kochanek, S
    JOURNAL OF GENE MEDICINE, 2004, 6 : S164 - S171
  • [7] Improved high-capacity adenoviral vectors for high-level neuron-restricted gene transfer to the CNS
    Hermening, Stephan
    Kuegler, Sebastian
    Baehr, Mathias
    Isenmann, Stefan
    JOURNAL OF VIROLOGICAL METHODS, 2006, 136 (1-2) : 30 - 37
  • [8] High-capacity 'gutless' adenoviral vectors
    Kochanek, S
    Schiedner, G
    Volpers, C
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2001, 3 (05) : 454 - 463
  • [9] Targeting of high-capacity adenoviral vectors
    Biermann, V
    Volpers, C
    Hussmann, S
    Stock, A
    Kewes, H
    Schiedner, G
    Herrmann, A
    Kochanek, S
    HUMAN GENE THERAPY, 2001, 12 (14) : 1757 - 1769
  • [10] High-capacity adenovirus vectors for stem and progenitor cell gene transfer
    Goncalves, Manuel A. F.
    Holkers, Maarten
    van Nierop, Gijsbert J.
    Knaaen-Shanzer, Shoshan
    de Vries, Antoine A. F.
    HUMAN GENE THERAPY, 2007, 18 (10) : 1042 - 1043
12345